TGF-β-YY1 signaling as a key driver of immune evasion in pancreatic cancer: Therapeutic implications
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy characterized by a dense desmoplastic stroma, profound immune suppression, and resistance to conventional therapeutics. Poor patient outcomes are driven by resistance to chemotherapy and imm... ...
